• PIN71 CLINICAL AND ECONOMIC BURDEN OF PEDIATRIC INFLUENZA IN NINE EUROPEAN COUNTRIES

    Nov 1, 2010, 00:00

  • PIN61 INFLUENZA RISK AND VACCINATION RATES IN EUROPE- A NATIONWIDE SURVEY OF ADULTS

    Nov 1, 2010, 00:00

  • PCV36 BUDGET IMPACT MODEL OF VENOUS THROMBOEMBOLISM PREVENTION AFTER TOTAL HIP AND KNEE REPLACEMENT

    Nov 1, 2010, 00:00

  • PCN18 ECONOMIC IMPLICATIONS OF THE FIRST-LINE TREATMENT OF ADVANCED RENAL CELL CARCINOMA IN THAILAND- A COST EFFECTIVENESS ANALYSIS

    Nov 1, 2010, 00:00

  • PRS49 TESTING THE USABILITY AND LANGUAGE OF E-PRO TRANSLATIONS DURING LINGUISTIC VALIDATION- COGNITIVE DEBRIEFING ON E-DEVICE VS. PRINT OUTSCREENSHOTS

    Nov 1, 2010, 00:00

  • PCN81 COST-EFFECTIVENESS ANALYSIS OF THREE STRATEGIES OF ERLOTINIB TREATMENT IN NON0-SMALL-CELL LUNG CANCER-A PROSPECTIVE MULTICENTRIC FRENCH STUDY (ERMETIC)

    Nov 1, 2010, 00:00

  • PUK1 CONTRAST-INDUCED NEPHROPATHY IN PATIENTS WITH CHRONIC KIDNEY DISEASE UNDERGOING COMPUTED TOMOGRAPHY- A COMPARATIVE SAFETY META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

    Nov 1, 2010, 00:00

  • PIH36 ASSISTED REPRODUCTIVE TECHNOLOGIES- A HEALTH TECHNOLOGY ASSESSMENT PERSPECTIVE

    Nov 1, 2010, 00:00

  • HT2 COST-EFFECTIVENESS OF INTERVENTIONS FOR REDUCING ROAD TRAFFIC INJURIES RELATED TO DRIVING UNDER THE INFLUENCE OF ALCOHOL

    Nov 1, 2010, 00:00

  • PHP9 BUDGET IMPACT ANALYSIS OF ORPHAN DRUGS IN BELGIUM- ESTIMATES FROM 2008 TO 2013

    Nov 1, 2010, 00:00

  • PMS55 ANALYSIS ON THE POSSIBLE ASSOCIATION BETWEEN RHEUMATOID ARTHIRITIS AND DIABETES MELLITUS TYPE 2

    Nov 1, 2010, 00:00

  • PMH13 ASSOCIATION OF MEDICATION PERSISTENCE AND HEALTH-CARE UTILIZATION IN HIGH-COST PATIENTS WITH MAJOR DEPRESSIVE DISORDER TREATED WITH DULOXETINE OR VENLAFAXINE XR

    Nov 1, 2010, 00:00

  • PHP92 COST-EFFECTIVENESS OF KNOWLEDGE TRANSLATION METHODS

    Nov 1, 2010, 00:00

  • PIN1 SURGICAL SITE INFECTION IN CHINA- A SYSTEMATIC REVIEW OF THE INCIDENCE AND ECONOMIC BURDEN

    Nov 1, 2010, 00:00

  • PND36 HEALTH STATUS COMPARISON BETWEEN STABLE PARKINSONS DISEASE PATIENTS AND THOSE EXPERIENCING OFF-TIME

    Nov 1, 2010, 00:00

  • PHP12 THE PUBLICS PREFERENCE ON THE PRIORITIES IN HEALTH CARE

    Nov 1, 2010, 00:00

  • PIN76 THE USE OF ECONOMIC ANALYSIS IN VACCINE EXPERT REVIEWS

    Nov 1, 2010, 00:00

  • PCV142 AN APPLICATION OF IMPUTATION TECHNIQUES TO IMPROVE DATA AVAILABILITY FROM ELECTRONIC MEDICAL RECORDS

    Nov 1, 2010, 00:00

  • MT3 COMPARATIVE EFFECTIVENESS OF ANTIDEPRESSANTS (AD) IN THE TREATMENT OF THE ELDERLY WITH MAJOR DEPRESSIVE DISORDER (MDD)-A MIXED TREATMENT COMPARISON AND META-REGRESSION ANALYSIS

    Nov 1, 2010, 00:00

  • PMC33 ESTIMATING HEALTH STATE UTILITY VALUES FOR COMORBID HEALTH CONDITIONS

    Nov 1, 2010, 00:00

  • PMC51 CONCEPT ELABORATION-AN ESSENTIAL STAGE IN THE TRANSLATION OF PRO MEASURES

    Nov 1, 2010, 00:00

  • PSS36 ECONOMIC ANALYSIS OF CATARACT SURGERY IN EUROPE-AN ANALYSIS OF HOSPITAL DATABASES AVAILABLE IN 11 COUNTRIES

    Nov 1, 2010, 00:00

  • PHP6 ROUTINE OF PATIENTS REDIRECTION IN THE HUNGARIAN PRIMARY CARE

    Nov 1, 2010, 00:00

  • PRS15 THE POTENTIAL COST IMPACT OF USING A PEG HYDROGEL SEALANT TO PREVENT AIR LEAKS AFTER LUNG RESECTION SURGERY IN ITALY

    Nov 1, 2010, 00:00

  • ME1 METHODOLOGICAL ISSUES IN THE DEVELOPMENT OF AN AUSTRALIAN ALGORITHM FOR THE EQ-5D

    Nov 1, 2010, 00:00

  • PUK2 COMPARING THE RISK OF DEATH BETWEEN PERITONEAL DIALYSIS AND HEMODIALYSIS IN TAIWANS ESRD POPULATION

    Nov 1, 2010, 00:00

  • PCN3 CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING EVENTS BY CHEMOTHERAPY EMETOGENICITY IN PATIENTS WITH CANCER TREATED IN A HOSPITAL OUTPATIENT SETTING

    Nov 1, 2010, 00:00

  • PHP39 A COMPARISON OF GENERIC AND ORIGINATOR BRAND DRUG PRICES BETWEEN JORDAN AND THE UNITED KINGDOM

    Nov 1, 2010, 00:00

  • PMH57 REVIEW OF CO-MORBIDITY OF EATING AND BODY DYSMORPHIC DISORDERS

    Nov 1, 2010, 00:00

  • PCN112 PATIENT CHARACTERISTICS, MEDICATION USE, RESOURCE USE AND MEDICAL COSTS AMONG PATIENTS WITH METASTATIC PANCREATIC CANCER (MPC)

    Nov 1, 2010, 00:00

  • PRS33 ECONOMIC EVALUATION OF ILOPROST, EPOPROSTENOL AND TREPROSTINIL FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION

    Nov 1, 2010, 00:00

  • PGI18 ECONOMICS OF A SYMPTOM BASED PATIENT MANAGEMENT APPROACH FOR GASTRO-ESOPHAGEAL REFLUX DISEASE (GERD), USING GERDQ, COMPARED TO AN INVASIVE APPROACH USING GASTROSCOPY AND PH-METRY

    Nov 1, 2010, 00:00

  • PSS38 USE OF CALL CENTRE METHODOLOGY TO COLLECT QUALITY OF LIFE (QOL) DATA IN A CLINICAL TRIAL- A CASE STUDY OF PATIENTS WITH DIABETIC MACULAR EDEMA (DME)

    Nov 1, 2010, 00:00

  • PUK19 ECONOMIC EVALUATION OF ALISKIREN IN TYPE 2 DIABETES AND HYPERTENSION PATIENTS WITH NEPHROPATHY IN MEXICO

    Nov 1, 2010, 00:00

  • PCN4 CANCER SYMPTOM SURVEY AND RELIABILITY ANALYSIS

    Nov 1, 2010, 00:00

  • DB1 EVALUATING THE COST-EFFECTIVENESS OF THERAPY CONVERSION FROM BASAL INSULIN TO BIPHASIC INSULIN ASPART 30/70 IN PATIENTS WITH TYPE 2 DIABETES IN CHINA- A MODELING STUDY OF LONG-TERM COSTS AND HEALTH OUTCOMES

    Nov 1, 2010, 00:00

  • PCV12 THE ECONOMIC BURDEN OF ATRIAL FIBRILLATION AND FLUTTER IN KOREA

    Nov 1, 2010, 00:00

  • PHP135 THE EXAMINATION OF THE CHRONIC STRESS

    Nov 1, 2010, 00:00

  • PCV39 DOSE STATIN USE IN PATIENTS WITH DIABETES SAVE DOWNSTREAM RESOURCE UTILIZATION? A DIFFERENCE-IN DIFFERENCES ANALYSIS

    Nov 1, 2010, 00:00

  • PMS1 THE LONG-TERM UTILIZATION AND SAFETY OF BIOLOGICAL AGENTS IN TREATING RHEUMATOID ARTHRITIS PATIENTS-A POPULATION-BASED CASE STUDY IN SOUTHERN TAIWAN

    Nov 1, 2010, 00:00

  • AD4 THE IMPACT OF PHARMACIST INTERVENTION ON PATIENTS ADHERENCE TO ANTIDEPRESSANT MEDICATION AND PATIENTREPORTED OUTCOMES

    Nov 1, 2010, 00:00

  • PSS6 ASTIGMATISM AND COST OF POST-CATARACT SURGERY SPECTACLE WEAR IN KOREA

    Nov 1, 2010, 00:00

  • PHP72 ANALYSIS THE AVERAGE SOJOURN TIME AND BOTTLENECK AFTER A DISASTER IN HOSPITALS

    Nov 1, 2010, 00:00

  • PCV3 COMPARISON OF MORTALITY, HEALTH CARE UTILITY AND COST OF PATIENTS WITH WARFARIN TREATMENT FOR NON-VALVULAR ATRIAL FIBRILLATION VERSUS PATIENTS WITH OTHER TREATMENT

    Nov 1, 2010, 00:00

  • PCV16 INPATIENT MANAGEMENT AND COSTS OF ACUTE CORONARY SYNDROMES IN FACULTY HOSPITAL- COMPARISON OF STEMI AND NON-STEMI

    Nov 1, 2010, 00:00

  • PCV30 PREVALENCE AND CONTROL OF TRADITIONAL CARDIOVASCULAR RISK FACTORS AND ANTICIPATED AVOIDABLE CORONARY MORTALITY IN PRIMARY PREVENTION IN EUROPE-THE EURIKA STUDY

    Nov 1, 2010, 00:00

  • PCV27 INCREASING PREVALENCE OF HYPERTENSION IN NIGERIA-A SYSTEMATIC REVIEW FROM 1990 TO 2009

    Nov 1, 2010, 00:00

  • PCV68 POTENTIAL COST-EFFECTIVENESS OF A BIOMARKER TEST TO RECLASSIFY PATIENTS WITH AN INTERMEDIATE RISK BASED ON THE FRAMINGHAM RISK SCORE INTO A LOWER OR HIGHER CATEGORY TO OPTIMIZE STATIN THERAPY

    Nov 1, 2010, 00:00

  • PMH16 PHARMACIST-RUN METHADONE CLINIC IN A MALAYSIAN PUBLIC HEALTH CENTER- EVALUATING PATIENT SATISFACTION AND QUALITY OF LIFE OUTCOMES

    Nov 1, 2010, 00:00

  • PHP1 ORPHAN DRUGS- DOES SOCIETY VALUE RARITY?

    Nov 1, 2010, 00:00

  • PCN132 ERLOTINIB MAINTENANCE THERAPY FOR NON-SMALL CELL LUNG CANCER PRESERVES QUALITY OF LIFE

    Nov 1, 2010, 00:00

  • PMH31 THE COST-EFFECTIVENESS OF ARIPIPRAZOLE IN PATIENTS WITH BIPOLAR I DISORDER IN THE UK

    Nov 1, 2010, 00:00

  • PHP113 LEVELS OF MEDICATION USE AMONG GERIATRIC PATIENTS IN ACUTE GERIATRIC CARE SETTINGS IN AUSTRIA

    Nov 1, 2010, 00:00

  • PND26 MEDICO-ECONOMIC EVALUATION OF LACOSAMIDE ADJUNCTIVE THERAPY IN THE TREATMENT OF PATIENTS WITH REFRACTORY EPILEPSY IN SCOTLAND AND SPAIN

    Nov 1, 2010, 00:00

  • PDB30 GLYCEMIC CONTROL IS WORSE AND COMPLICATIONS MORE PREVALENT IN TYPE 2 DIABETES PATIENTS WITH A HIGHER BMI IN CHINA

    Nov 1, 2010, 00:00

  • PDB1 HYPOGLYCEMIA-RELATED HEALTH-CARE UTILIZATION FOLLOWING INITIATION OF INSULIN ASPART IN A VIAL/SYRINGE OR IN A PREFILLED DISPOSABLE PEN (FLEXPEN).ANALYSIS OF REAL-WORLD UTILIZATION IN THE UNITED STATES

    Nov 1, 2010, 00:00

  • PHP36 THE AVAILABILITY AND FUNDING OF ORPHAN DRUGS IN BOSNIA AND HERZEGOVINA IN COMPARISON WITH NEIGHBORING COUNTRIES

    Nov 1, 2010, 00:00

  • PUK3 ASSESSMENT OF COMORBIDITIES IN PATIENTS WITH OVERACTIVE BLADDER (OAB) DISORDER- AN ELECTRONIC MEDICAL RECORD (EMR) DATA ANALYSIS

    Nov 1, 2010, 00:00

  • PMS52 PREFERENCES OVER BENEFITS AND RISKS ASSOCIATED WITH THE USE OF NSAIDS- EVIDENCE FROM PATIENTS DIAGNOSED WITH OSTEOARTHRITIS (OA) IN UK

    Nov 1, 2010, 00:00

  • PRS48 COMPARISON OF ECONOMETRIC MODELS FOR ESTIMATING COST DIFFERENCES- OLS, GAMMA, AND QUANTILE REGRESSION

    Nov 1, 2010, 00:00

  • PCN87 PHARMACOECONOMIC ANALYSIS OF DIRECT MEDICAL COSTS OF METASTATIC COLORECTAL CANCER THERAPY WITH XELOX OR FOLFOX4 WITH OR WITHOUT BEVACIZUMAB AS THE FIRST-LINE TREATMENT

    Nov 1, 2010, 00:00

  • PCV91 THE COST-EFFECTIVENESS OF ROSUVASTATIN VERSUS ATORVASTATIN FOR THE PREVENTION OF CARDIOVASCULAR MORBIDITY AND MORTALITY IN PATIENTS WITH HIGH BASELINE RISK-A SWEDISH ECONOMIC EVALUATION OF THE JUPITER TRIAL

    Nov 1, 2010, 00:00

  • PMS46 DOSING PROFILE COMPARISON BETWEEN PATIENTS WITH FIBROMYALGIA INITIATING DULOXETINE AND PREGABALIN IN 2007- A LARGE NATIONAL RETROSPECTIVE COHORT STUDY

    Nov 1, 2010, 00:00

  • PMS64 CONSUMPTION OF BISPHOSPHONATES FOR THE TREATMENT OF OSTEOPOROSIS

    Nov 1, 2010, 00:00

  • PDB90 IMPROVING PATIENT CARE- RESULTS FROM THE TEXAS NEWBORN SCREENING PERFORMANCE MEASURES PROJECT

    Nov 1, 2010, 00:00

  • PCN144 CURRENT CHEMOTHERAPY AND MONOCLONAL ANTIBODY USE PATTERNS IN METASTATIC COLORECTAL CANCER IN WESTERN EUROPE

    Nov 1, 2010, 00:00

  • PHP14 THE JOINT COMMITTEE FOR NEW DRUGS EVALUATION IN SPAIN- 6 YEARS OF EXPERIENCE

    Nov 1, 2010, 00:00

  • PIH5 PHARMACOEPIDEMIOLOGICAL BURDEN OF PREGNANCY IN BELARUS

    Nov 1, 2010, 00:00

  • PCN143 PRIMARY PREVENTION AS EXPANDED INDICATION TO MITIGATE COMPETITION-A CASE STUDY

    Nov 1, 2010, 00:00

  • PGI13 MODELING THE LONG TERM CONSEQUENCES OF SUPPRESSING VIRAL REPLICATION IN CHRONIC HEPATITIS B- A COSTEFFECTIVENESS ANALYSIS OF ENTECAVIR (BARACLUDE) IN TURKEY

    Nov 1, 2010, 00:00

  • PCV57 COST ANALYSIS OF THE MEDICINE TREATMENT OF SOUTH AFRICAN PATIENTS WITH METABOLIC SYNDROME

    Nov 1, 2010, 00:00

  • PCV17 ESTIMATING COST OF INPATIENT CORONARY ANGIOGRAPHY USING STEP DOWN METHOD AT UNIVERSITY KEBANGSAAN MALAYSIA MEDICAL CENTER

    Nov 1, 2010, 00:00

  • PSY3 CLINICAL AND ECONOMIC OUTCOMES OF ZICONOTIDE NEUROMODULATION IN ITALIAN CANCER PATIENTS

    Nov 1, 2010, 00:00

  • PIN47 COST-EFFECTIVENESS ANALYSIS OF PNEUMOCOCCAL VACCINES IN TAIWAN

    Nov 1, 2010, 00:00

  • PHP82 ASSESSMENT OF PHARMACEUTICAL EXPENDITURE TRENDS IN PORTUGAL-PRICING AND REIMBURSEMENT POLICY

    Nov 1, 2010, 00:00

  • PCV15 META-REGRESSION APPROACH TO IDENTIFY THE EQUIVALENCE DOSE RATIOS OF ROSUVASTATIN TO SIMVASTATIN AND ATORVASTATIN

    Nov 1, 2010, 00:00

  • PCV119 SURVEY AT RETAIL PHARMACIES LEVEL ASSESSING QUALITY OF LIFE OF VKAS PATIENTS

    Nov 1, 2010, 00:00

  • PIH22 DO LOW-INCOME GROUPS IN PAKISTAN UNDERSTAND THE CONCEPT OF GENERIC MEDICINES?

    Nov 1, 2010, 00:00

  • PCV47 ASSOCIATION BETWEEN HOSPITAL PROCESS PERFORMANCE AND OUTCOME OF PATIENTS WITH ACUTE MYOCARIDAL INFARCTION

    Nov 1, 2010, 00:00

  • PDB4 MEDICAL SERVICE COST ASSOCIATED WITH PIOGLITAZONE AND SULFONYLUREA TREATMENT AMONG TYPE 2 DIABETIC PATIENTS ENROLLED IN A US INTEGRATED HEALTH-CARE SYSTEM

    Nov 1, 2010, 00:00

  • PMH30 ECONOMIC EVALUATION OF AGOMELATINE IN MAJOR DEPRESSIVE DISORDERS IN IRELAND

    Nov 1, 2010, 00:00

  • PGI10 MODELLING THE IMPACT OF TREATMENT WITH ENTECAVIR ON HEALTH CARE COSTS OF CHRONIC HEPATITIS B IN FRANCE

    Nov 1, 2010, 00:00

  • PMS65 RETROSPECTIVE OBSERVATIONAL DATABASE ANALYSIS OF TNF- INHIBITOR SWITCHING PATTERNS IN PATIENTS IN THE UNITED STATES WITH RHEUMATOID ARTHRITIS IN TWO DISTINCT 'NATURALISTIC' TREATMENT SETTINGS USING A PRE-PROGRAMMED DATA ANALYSIS TOOL

    Nov 1, 2010, 00:00

  • PDB95 SIMPLIFICATION OF PATIENT LEVEL SIMULATIONS TO COHORT MODEL FOR SCENARIO ANALYSIS

    Nov 1, 2010, 00:00

  • PR3 THE IMPACT OF FINNISH PHARMACEUTICAL PRICING SCHEME IN COST-EFFECTIVENESS ANALYSES

    Nov 1, 2010, 00:00

  • PDB63 LIRAGLUTIDE IN THE TREATMENT OF TYPE 2 DIABETES MIELLITUS-ECONOMIC EVALUATION IN ROMANIAN SETTING

    Nov 1, 2010, 00:00

  • PCV43 OFFSETTING ANNNUAL CARDIOVASCULAR DISEASE-RELATED MEDICAL AND PHARMACY COSTS BETWEEN PATIENTS CONTINUING STATIN MONOTHERAPY OR AUGMENTING STATIN MONOTHERAPY WITH NIACIN EXTENDED-RELEASE

    Nov 1, 2010, 00:00

  • PCN72 COST-EFFECTIVENESS OF LETROZOLE AND OF ANASTROZOLE VERSUS TAMOXIFEN AS ADJUVANT THERAPY IN POSTMENOPAUSAL WOMEN WITH EARLY BREAST CANCER USING UPDATED SURVIVAL DATA FROM THE BIG 1-98 AND ATAC TRIALS-A UK PERSPECTIVE

    Nov 1, 2010, 00:00

  • PMC23 PROPOSED METHODS FOR CONDUCTING SENSITIVITY ANALYSES ON THRESHOLD-DERIVED ESTIMATES OF VALUE-BASED PRICE AND PRODUCT PROFILES FOR EARLY-STAGE DRUGS

    Nov 1, 2010, 00:00

  • PCV29 DESIGN OF A DISCRETE CHOICE EXPERIMENT TO QUANTIFY CONSUMER PREFERENCES FOR CHRONIC HEART FAILURE MANAGEMENT PROGRAMS

    Nov 1, 2010, 00:00

  • PHP35 THE IMPACT OF THE HOSPITAL FUNDING SYSTEM ON THE RANGE OF THE EXPENSIVE DRUGS AVAILABLE IN FRENCH AND ENGLISH HOSPITALS

    Nov 1, 2010, 00:00

  • PHP65 VALUE BASED PRICING IN THE UK-A SURVEY-BASED APPROACH

    Nov 1, 2010, 00:00

  • PCN63 SURVEY AND ANALYSIS OF THE COSTS OF METASTATIC COLORECTAL CANCER TREATMENT IN SERBIA

    Nov 1, 2010, 00:00

  • PMC28 CLINICIAN REPORTED OUTCOMES- ISSUES IN THE TRANSLATION AND LINGUISTIC VALIDATION

    Nov 1, 2010, 00:00

  • PMS12 INCREASE OF INJECTION THERAPY ON PATIENTS WITH LOW BACK PAIN IN SOUTH KOREA (2006-2008)

    Nov 1, 2010, 00:00

  • PDB12 TIME TO OPIOID USE AMONG COMMERCIALLY-INSURED PATIENTS WITH DIABETIC PERIPHERAL NEUROPATHIC PAIN WHO INITIATED DULOXETINE VERSUS OTHER TREATMENTS-A PROPENSITY SCORE APPROACH

    Nov 1, 2010, 00:00

  • DS3 A COMPARISON OF SIGNAL DETECTION PERFORMANCE BETWEEN REPORTING ODDS RATIO AND BAYESIAN CONFIDENCE PROPAGATION NEURAL NETWORK METHODS ON ADVERSE DRUG REACTION SPONTANEOUS REPORTING DATABASE OF THE THAI FDA

    Nov 1, 2010, 00:00

  • VA1 ARE THE BENEFITS OF FLU VACCINATION IN THE ELDERLY CORRECTLY SIMULATED IN ECONOMIC ASSESSMENT MODELS?

    Nov 1, 2010, 00:00

  • PCV81 THE COMPARATIVE ANALYSIS OF THE EFFECTIVENESS AND THE COSTS OF USING THE LOW-MOLECULAR-WEIGHT HEPARINS AND THE ORAL ANTICOAGULANTS FOR THE TREATMENT OF THE VENOUS THROMBOEMBOLISM IN POLAND

    Nov 1, 2010, 00:00

  • PND27 COST UTILITY ANALYSIS OF ORPHAN DRUGS- CASE STUDY OF DUODENAL LEVODOPA INFUSION VERSUS STANDARD TREATMENT IN PATIENTS WITH ADVANCED PARKINSONS DISEASE IN SWEDEN

    Nov 1, 2010, 00:00

  • PDB8 COST-EFFECTIVENESS OF SWITCHING PATIENTS EITH TYPE 2 DIABETES FROM INSULIN GLARGINE TO INSULIN DETEMIR IN A CHINESE SETTING- A HEALTH ECONOMIC MODEL BASED ON THE PREDICTIVE STUDY

    Nov 1, 2010, 00:00

  • PCN5 EFFICACY OF PALONOSETRON (PAL) COMPARED TO OTHER SEROTONIN INHIBITORS (5-HT3R) IN PREVENTING CHEMOTHERAPYINDUCED NAUSEA AND VOMITING (CINV) IN PATIENTS RECEIVING MODERATELY OR HIGHLY EMETOGENIC (MOHE) TREATMENT- AN UPDATE OF THE PREVIO ...

    Nov 1, 2010, 00:00

  • PIN48 PHARMACO-ECONOMICS OF ANTIBIOTICS

    Nov 1, 2010, 00:00

  • PCN28 UTILIZATION OF ANTIEMETIC PROPHYLAXIS ALONGSIDE CHEMOTHERAPY IN FOUR EUROPEAN COUNTRIES

    Nov 1, 2010, 00:00

  • PHP124 DESCRIPTION OF THE PRICING AND REIMBURSEMENT SYSTEM IN THE CZECH REPUBLIC

    Nov 1, 2010, 00:00

  • PMS2 GASTROINTESTINAL AND CARDIOVASCULAR RISK OF NONSELECTIVE NSAIDS AND COX-2 INHIBITORS IN ELDERLY PATIENTS WITH KNEE OSTEOARTHRITIS

    Nov 1, 2010, 00:00

  • PGI30 ASSESSMENT OF FEASIBILITY OF THE METHODOLOGICAL APPROACH DESCRIBED IN THE MODEL FOR THE REGULATION OF REIMBURSEMENT PRICES IN GERMANY

    Nov 1, 2010, 00:00

  • PMH63 ANTIPSYCHOTIC PRESCRIBING TO THE ELDERLY-A TWO-YEAR COMPARATIVE ANALYSIS

    Nov 1, 2010, 00:00

  • PCN134 DEALING WITH CULTURALLY SENSITIVE QUESTIONS IN THE COURSE OF TRANSLATING EORTC QUALITY-OF-LIFE GROUP QUESTIONNAIRES

    Nov 1, 2010, 00:00

  • PIH5 MEDICAL COST AND UTILIZATION FOR PATIENTS WITH POSTPARTUM HEMORRHAGE IN KOREA

    Nov 1, 2010, 00:00

  • PND47 APPLICATION OF THE KANO METHODOLOGY FOR EVALUATING MIGRAINE TREATMENT EXPECTATIONS AMONG PATIENTS TREATED BY NEUROLOGISTS IN SPAIN-THE MIGREXX STUDY

    Nov 1, 2010, 00:00

  • PHP17 ACCESSIBILITY TO ORPHAN DRUGS IN JAPAN-HAS THE ORPHAN DESIGNATION SYSTEM CONTRIBUTED?

    Nov 1, 2010, 00:00

  • PR2 DECIDING ON VALUE FOR MONEY-A COMPARISON OF THE DUTCH, BELGIAN, SWEDISH, AND FRENCH DRUG REIMBURSEMENT SYSTEMS

    Nov 1, 2010, 00:00

  • PHP4 EFFECTIVENESS OF TWO POLICIES TO REDUCE DIPHENOXYLATE CONSUMPTION IN IRAN

    Nov 1, 2010, 00:00

  • PIH11 IDENTIFYING COST-EFFECTIVE TREATMENT WITH RALOXIFENE IN POSTMENOPAUSAL WOMEN USING RISK ALGORITHMS FOR FRACTURES AND INVASIVE BREAST CANCER

    Nov 1, 2010, 00:00

  • PSS1 META-ANALYSIS OF PARTIALLY HYDROLYZED 100-WHEY FORMULA VERSUS EXTENSIVELY HYDROLYZED FORMULAS IN THE PREVENTION OF ATOPIC DERMATITIS

    Nov 1, 2010, 00:00

  • PCN46 ECONOMIC EVALUATION OF ONCOTYPE DX TO TARGET CHEMOTHERAPY USE IN LYMPH-NODE-NEGATIVE, OESTROGENRECEPTOR-POSITIVE, EARLY-STAGE BREAST CANCER IN IRELAND

    Nov 1, 2010, 00:00

  • PCN138 HEALTH-CARE COSTS ASSOCIATED WITH BREAST CANCER MANAGEMENT

    Nov 1, 2010, 00:00

  • PMH43 HEALTH CARE UTILIZATION OF PATIENTS WITH DEPRESSION BEFORE AND AFTER INTIATING DULOXETINE

    Nov 1, 2010, 00:00

  • PMS40 COST-EFFECTIVENESS OF DENOSUMAB COMPARED WITH GENERIC ALENDRONATE IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROTIC WOMEN

    Nov 1, 2010, 00:00

  • PCN17 ECONOMIC EVALUATION OF PEMETREXED IN PATIENTS WITH PREVIOUSLY TREATED ADVANCED NON-SMALL CELL LUNG CANCER IN JAPAN

    Nov 1, 2010, 00:00

  • PRS14 THE POTENTIAL COST IMPACT OF USING A PEG HYDROGEL SEALANT TO PREVENT AIR LEAKS AFTER LUNG RESECTION SURGERY IN SPAIN

    Nov 1, 2010, 00:00

  • PIN1 COST AND QUALITY OF LIFE ISSUES ASSOCIATED WITH PROTEASE INHIBITOR-BASED COMBINATION THERAPY TO TREAT HEPATITIS C

    Nov 1, 2010, 00:00

  • PCV128 MODELING OF HEALTH SERVICE RESEARCH RESULTS WITH UPDATED COST DATA-THE GERSHWIN STUDY EXAMPLE

    Nov 1, 2010, 00:00

  • PMH2 EARLY RESPONSE PREDICTS SUBSEQUENT RESPONSE TO OLANZAPINE LONG-ACTING INJECTIONS IN THE TREATMENT OF SCHIZOPHRENIA

    Nov 1, 2010, 00:00

  • PIH34 CONTENT VALIDITY OF THE BENIGN PROSTATIC HYPERPLASIA IMPACT INDEX (BII)- RESULTS FROM CONCEPT ELICITATION AND COGNITIVE INTERVIEWS

    Nov 1, 2010, 00:00

  • PCV45 COST-EFFECTIVENESS ANALYSIS OF ROSUVASTATIN VERSUS ATORVASTATIN IN TURKEY- AN ANALYSIS BASED ON THE SYSTEMATIC REVIEW OF PUBLISHED RANDOMIZED CLINICAL TRIALS (RCTS)

    Nov 1, 2010, 00:00

  • RS3 THE BAYESIAN APPROACH FOR PERFORMANCE-BASED PRICING-A CASE STUDY IN JAPAN

    Nov 1, 2010, 00:00

  • PCN94 CAPECITABINE OXALIPLATIN (FOLFOX4) IN THE ADJUVANT TREATMENT OF PATIENTS WITH COLON CANCER (ACC)- COMPARISON OF DIRECT MEDICAL AND SOCIETAL (INDIRECT) COSTS

    Nov 1, 2010, 00:00

  • PHP98 COST-EFFECTIVENESS METHODOLOGIES OF STRATEGIES THAT AIM TO CHANGE THE BEHAVIOUR OF HEALTH CARE PROFESSIONALS

    Nov 1, 2010, 00:00

  • PCV38 UTILIZATION, PRICE, AND EXPENDITURE TRENDS FOR ANGIOTENSIN RECEPTOR BLOCKERS IN THE MEDICAID PROGRAM

    Nov 1, 2010, 00:00

  • PCV33 THE IMPACT OF SWITCHING PATIENTS TO ROSUVASTATIN ON HEALTH-CARE EXPENDITURE AND PREVENTION OF CARDIOVASCULAR DISEASE- A COHORT STUDY

    Nov 1, 2010, 00:00

  • PRS51 ADVANCED PATTERN RECOGNITION METHODS FOR PREDICTING TREATMENT RESPONSE IN PATIENTS SUFFERING FROM ALLERGIC RHINITIS

    Nov 1, 2010, 00:00

  • PMH4 A PHASE IV STUDY OF THE EFFECTIVENESS OF QUETIAPINE EXTENDED RELEASE 600 MG ONCE A DAY TO CONTROL THE SYMPTOMS OF MANIC PHASE OF BIPOLAR DISORDER-THE EMMY TRIAL

    Nov 1, 2010, 00:00

  • PMS3 IMPROVEMENT IN EFFICACY AND SAFETY OUTCOMES AFTER CERVICAL ARTHROPLASTY VERSUS STANDARD ANTERIOR CERVICAL DISECTOMY AND FUSION (ACDF) SURGERIES-A META-ANALYSIS OF PUBLISHED RCTS

    Nov 1, 2010, 00:00

  • PIN27 AZITHROMYCIN OBSERVATIONAL STUDY IN BACTERIAL UPPER RESPIRATORY TRACT INFECTIONS IN INDIAN PATIENTS

    Nov 1, 2010, 00:00

  • PMC8 BURDEN OF DISEASE AND ECONOMIC EVALUATION- ARE WE INVESTIGATING WHAT IT REALLY MATTERS?

    Nov 1, 2010, 00:00

  • PCN76 A SIMULATION MODELLING APPROACH TO QUANTIFY THE COST-EFFECTIVENESS OF EXTRA-CORPOREAL PHOTOPHERESIS IN CHRONIC GRAFT VERSUS HOST DISEASE (CGVHD) IN SPAIN

    Nov 1, 2010, 00:00

  • MT1 DOES MODEL CHOICE IN MIXED TREATMENT COMPARISONS AFFECT THE OUTCOME FOR DECISION-MAKERS?

    Nov 1, 2010, 00:00

  • PUK18 COST-EFFECTIVENESS ANALYSIS OF TIMELY VERSUS LATE DIALYSIS REFERRAL AFTER RENAL TRANSPLANT FAILURE IN SPAIN

    Nov 1, 2010, 00:00

  • PCN161 DECISION-ANALYTIC MODELING IN CHRONIC MYELOID LEUKEMIA-A SYSTEMATIC OVERVIEW

    Nov 1, 2010, 00:00

  • PRS10 RACE AND ETHNICITY IN EMERGENCY ROOM AND NON-URGENT CARE VISITS AMONG LATINO CHILDREN SUFFERING FROM ASTHMA

    Nov 1, 2010, 00:00

  • PMS60 TNF THERAPY REDUCES THE ODDS OF WORSENING DISABILITY TRENDS IN RHEUMATOID ARTHRITIS OVER AT LEAST 2 YEARS-DATA FROM THE NDB-PORTUGAL COHORT

    Nov 1, 2010, 00:00

  • PMC49 THE ROLE OF PATIENT-REPORTED OUTCOMES (PRO) AS PRIMARY ENDPOINTS IN THE EVALUATION OF MEDICINES APPROVED WITH PRO CLAIMS

    Nov 1, 2010, 00:00

  • PHP76 ALLOCATION OF A SINGLE BUDGET FOR HEALTH CARE, PROFESSIONAL EDUCATION, AND RESEARCH

    Nov 1, 2010, 00:00

  • PCN99 COST-EFFECTIVENESS OF IMATINIB AS ADJUVANT TREATMENT FOR RESECTED GASTROINTESTINAL STROMAL TUMORS (GIST) VERSUS BEST SUPPORTIVE CARE- CANADIAN PERSPECTIVE

    Nov 1, 2010, 00:00

  • PMS75 MODELING OF RHEUMATOID ARTHRITIS- A METHODOLOGICAL APPROACH

    Nov 1, 2010, 00:00

  • PIN74 PARENTS DILEMMA WHETHER OR NOT TO VACCINATE THEIR CHILDREN AGAINST INFLUENZA A (H1N1)

    Nov 1, 2010, 00:00

  • PGI4 PREVALENCE AND INCIDENCE OF HEPATITIS A IN A UNITED STATES MANAGED CARE CLAIMS DATABASE

    Nov 1, 2010, 00:00

  • PSY46 INDIRECT COSTS OF MODERATE AND SEVERE FORMS OF PSORIASIS IN CZECH REPUBLIC- CALCULATION BASED ON SELF REPORTED QUESTIONNAIRE

    Nov 1, 2010, 00:00

  • PIH54 METFORMIN FOR THE TREATMENT OF CHILDHOOD OBESITY- A SYSTEMATIC REVIEW AND META-ANALYSIS

    Nov 1, 2010, 00:00

  • BL1 COST-EFFECTIVENESS, VALUE OF INFORMATION, AND BUDGET IMPACT OF CERTOLIZUMAB PEGOL COMPARED TO SUBCUTANEOUS TUMOR NECROSIS FACTOR (TNF) INHIBITORS AND METHOTREXATE IN THE TREATMENT OF MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS IN FINLAND

    Nov 1, 2010, 00:00

  • PIN26 ENVIRONMENTAL SITUATION OF DROP IN CENTERS FOR HIGH RISK POPULATION ON HIV/AIDS PREVENTION IN DHAKA, BANGLADESH

    Nov 1, 2010, 00:00

  • PDB68 HEALTH RELATED QUALITY OF LIFE (HRQL) AND EQ-5D UTILITIES IN A TYPE 2 DIABETES (T2D) POPULATION- RESULTS FROM A SWEDISH SURVEY

    Nov 1, 2010, 00:00

  • PDB37 THE COST-EFFECTIVENESS OF SAXAGLIPTIN VERSUS NPH INSULIN IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (T2DM) IN POLAND

    Nov 1, 2010, 00:00

  • PDB17 EVALUATING THE CHOICE OF PEN VERSUS SYRINGE- IMPLICATIONS FOR LONG-TERM DIABETES MANAGEMENT

    Nov 1, 2010, 00:00

  • PHP49 INFLUENCE OF THE CHRONIC DISEASE IN HEALTH RESOURCES USE- ECONOMICS CONSECUENCES AND RISK STRATIFICATION

    Nov 1, 2010, 00:00

  • PCV89 COST-EFFECTIVENESS OF DRONEDARONE FOR THE TREATMENT OF ATRIAL FIBRILLATION IN THE UK

    Nov 1, 2010, 00:00

  • PCV28 CARDIOVASCULAR RISK FACTORS AMONG ASIAN INDIAN AND WHITE ADULTS IN THE UNITED STATES

    Nov 1, 2010, 00:00

  • PCV27 ADHERENCE TO ANTIHYPERTENSIVE MEDICATIONS- A QUALITATIVE STUDY AMONG OUTPATIENTS VISITING PUBLIC HOSPITALS IN THE CITY OF QUETTA, PAKISTAN

    Nov 1, 2010, 00:00

  • PSY44 COST-EFFECTIVENESS OF A LIDOCAINE PLASTER RELATIVE TO GABAPENTIN AND PREGABALIN IN THE TREATMENT OF POSTHERPETIC NEURALGIA IN SPAIN

    Nov 1, 2010, 00:00

  • PSS11 MEDICATION CHOICE AND ASSOCIATED HEALTH-CARE OUTCOMES AND COSTS FOR PATIENTS WITH PSORIASIS IN THE UNITED STATES

    Nov 1, 2010, 00:00

  • PUK5 CLINICAL AND DEMOGRAPHIC CHARACTERISTICS OF PATIENTS IN RENAL REPLACEMENT THERAPY IN SO PAULO, BRAZIL

    Nov 1, 2010, 00:00

  • PSY10 A BUDGET IMPACT MODEL TO INVESTIGATE POTENTIAL COST SAVINGS ASSOCIATED WITH IMPROVEMENTS IN THE SAFETY PROFILE OF STRONG OPIOID ANALGESICS

    Nov 1, 2010, 00:00

  • PSS13 LINGUISTIC VALIDATION OF THE NATIONAL EYE INSTITUTE- QUALITY OF LIFE QUESTIONNAIRE-42 (NEI-RQL-42) FOR PATIENTS WITH REFRACTIVE ERROR MODIFIED FOR SIMPLIFIED CHINESE IN MAINLAND CHINA AND HINDI IN INDIA

    Nov 1, 2010, 00:00

  • PCV1 COST-EFFECTIVENESS OF ACUTE ISCHEMIC STROKE IN CHINA- MARKOV MATRIX ANALYSES

    Nov 1, 2010, 00:00

  • PHP56 SERVICES FOR WHICH PHARMACISTS MAY LEVY A FEE- PHARMACIST INITIATED THERAPY (PIT)

    Nov 1, 2010, 00:00

  • PRS39 QUALITY OF LIFE, PRODUCTIVITY LOSS, AND RESOURCE USE AMONG EMPLOYED ADULTS AGED 40 TO 64 YEARS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN THE UNITED STATES (US) WORKFORCE

    Nov 1, 2010, 00:00

  • PCN92 PHARMACOEPIDEMIOLOGICAL AND PHARMACOECONOMIC EVALUATION OF OXALIPLATIN IN PALLIATIVE CHEMOTHERAPY OF METASTATIC COLORECTAL CANCER (MCCR)

    Nov 1, 2010, 00:00

  • PMC24 LAST OBSERVATION CARRIED FORWARD (LOCF) VS. MIXED-EFFECTS MODEL REPEATED MEASURES (MMRM)- EMPIRICAL EVALUATION OF TWO APPROACHES TO ANALYZING LONGITUDINAL DATA WITH MISSING OBSERVATIONS

    Nov 1, 2010, 00:00

  • PIH62 ESTIMATING THE CROSS-SECTIONAL NUMBER AND GESTATIONAL AGE DISTRIBUTION OF PREGNANT WOMEN FOR ECONOMIC ANALYSIS

    Nov 1, 2010, 00:00

  • PHP11 NEW AND IMPROVED- DEFINING INNOVATION FOR HEALTH TECHNOLOGY POLICY

    Nov 1, 2010, 00:00

  • PCV2 SUCCESSFUL IMPLEMENTATION OF A PT APPROVED THERAPEUTIC INTERCHANGE PROGRAM OF ANGIOTENSIN II RECEPTOR BLOCKERS IN A MEDICAL CENTER IN TAIWAN

    Nov 1, 2010, 00:00

  • PHP64 VALUE BASED PRICING IN THE UK-A PRICE-QUANTITY MODEL ASSESSMENT

    Nov 1, 2010, 00:00

  • PHP47 EFFICIENCY IN DRUG PRESCRIPTION MEASURED BY THE APPLICATION OF ADJUSTED CLINICAL GROUPS IN THIRTEEN SPANISH PRIMARY CARE CENTRES

    Nov 1, 2010, 00:00

  • PMC22 REVENUE OPTIMIZATION MODEL TO OPTIMISE POSITION AND INDICATION OF NEW LAUNCHES

    Nov 1, 2010, 00:00

  • PHP3 THE VALUE OF PATIENT PERSPECTIVES IN THE DRUG DEVELOPMENT LIFECYCLE

    Nov 1, 2010, 00:00

  • PDB16 DEVELOPMENT OF A THAI VERSION OF THE AUDIT OF DIABETESDEPENDENT QUALITY OF LIFE (ADDQOL-19) QUESTIONNAIRE- LINGUISTIC AND PSYCHOMETRIC EVALUATION

    Nov 1, 2010, 00:00

  • PHP52 HIGH AND INTENSIVE UTILIZERS IN HEALTH CARE-A STRATEGIC CHALLENGE FOR MEDICAL SUPPLY IN THE COMPULSORY HEALTH INSURANCE

    Nov 1, 2010, 00:00

  • PRS25 A COST-UTILITY ANALYSIS FOR TIOTROPIUM BROMIDE IN THE LONG TERM TREATMENT OF SPECIFIC SUBGROUPS OF ITALIAN COPD PATIENTS

    Nov 1, 2010, 00:00

  • NI1 RETROSPECTIVE ANALYSIS OF TECHNOLOGY APPRAISALS CONDUCTED BY UKS NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE (NICE) IN SEVERAL CANCER INDICATIONS- HIGHER EVIDENCE BARRIERS FOR TARGETED THERAPIES?

    Nov 1, 2010, 00:00

  • PND8 THE POTENTIAL COST IMPACT OF USING A PEG HYDROGEL SEALANT COMPARED WITH FIBRIN SEALANT TO PREVENT CEREBRAL SPINAL FLUID LEAKS AFTER CRANIAL SURGERY IN THE UK

    Nov 1, 2010, 00:00

  • PCV60 COST OF ANALYSIS OF THE ADVERSE EFFECTS OF THE ANTIARRYTHMIC DRUGS IN THE CLINCAL PRACTICE IN SPAIN

    Nov 1, 2010, 00:00

  • PRS4 ASSESSMENT OF KNOWLEDGE ABOUT TUBERCULOSIS AMONG TB PATIENTS IN NORTH EAST LIBYA

    Nov 1, 2010, 00:00

  • PND20 IS ROPINIROLE-PROLONGED RELEASE A COST-SAVING TREATMENT OPTION IN PARKINSONS DISEASE?

    Nov 1, 2010, 00:00

  • PDB15 HEALTH STATUS, HEALTH-RELATED QUALITY OF LIFE AND TREATMENT SATISFACTION AMONG PATIENTS WITH DIABETES IN THAILAND

    Nov 1, 2010, 00:00

  • PUK4 LONG-TERM HEALTHCARE RESOURCE CONSUMPTION AMONG HEMODIALYSIS PATIENTS AND PERITONEAL DIALYSIS PATIENTS IN TAIWAN

    Nov 1, 2010, 00:00

  • PSY2 POTENTIAL COST SAVINGS ASSOCIATED WITH FASTER BLEEDING RESOLUTION IN THE INPATIENT TREATMENT OF HEMOPHILIA WITH INHIBITORS

    Nov 1, 2010, 00:00

  • PMH71 THE APPLICABILITY OF THE QALY AS EFFECT MEASURE IN CRIMINAL YOUTHS

    Nov 1, 2010, 00:00

  • PDB58 PHARMACOEPIDEMIOLOGICAL ASSAY AND COST-MINIMIZATION ANALYSIS OF ORAL ANTIDIABETIC MEDICATIONS AND INSULINS IN LITHUANIA

    Nov 1, 2010, 00:00

  • PDB24 DIRECT HEALTH CARE COSTS OF DIABETES MELLITUS IN HUNGARY

    Nov 1, 2010, 00:00

  • PDB85 APPROVAL AFTER REJECTION-AN INSIGHT IN HTA RE-EVALUATIONS

    Nov 1, 2010, 00:00

  • PCV137 A SYSTEMATIC REVIEW ON DISEASE BURDEN AND UNMET NEEDS FOR VENOUS THROMBOEMBOLISM IN HOSPITALISED MEDICAL PATIENTS IN EUROPE SHOWS UNDER-UTILIZATION OF PREVENTIVE THERAPIES

    Nov 1, 2010, 00:00

  • PCN11 GEFITINIB COMPARED WITH DOUBLET CHEMOTHERAPY FOR FIRST-LINE TREATMENT OF NON-SMALL-CELL LUNG CANCER (NSCLC)- A SYSTEMATIC REVIEW AND ADJUSTED INDIRECT COMPARISON

    Nov 1, 2010, 00:00

  • PMC5 DEVELOPMENT OF A WEB-BASED SOFTWARE TOOL TO EVALUATE THE ECONOMIC IMPACT OF LOST PRODUCTIVITY DUE TO PREMATURE MORTALITY IN DEVELOPED AND EMERGING NATIONS

    Nov 1, 2010, 00:00

  • PIN45 COST-EFFECTIVENESS ANALYSIS OF TREATMENT OF CHRONIC HEPATITIS C PATIENTS WITH PEGINTERFERON ALFA-2A OR PEGINTERFERON ALFA-2B BOTH PLUS RIBAVIRIN IN SPAIN

    Nov 1, 2010, 00:00

  • PIH21 IS ROUTINE IMMUNIZATION OF ELDERLY WITH THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE LIKELY TO BE CONSIDERED AS COST-EFFECTIVE?

    Nov 1, 2010, 00:00

  • PDB5 TOTAL AND DIABETES-RELATED COSTS ASSOCIATED WITH HYPOGLYCEMIA IN TYPE 2 DIABETES MELLITUS PATIENTS INITIATED ON ORAL ANTIDIABETIC DRUGS FROM A LARGE US MANAGED CARE COHORT

    Nov 1, 2010, 00:00

  • PND43 IMPACT OF MEMANTINE TREATMENT INITIATION ON PSYCHOTROPICS USE- ANALYSES WITH THE RAMQ DATABASE

    Nov 1, 2010, 00:00

  • PCN101 COST-UTILITY ANALYSIS OF DASATINIB AS A SECOND-LINE TREATMENT IN THE CHRONIC PHASE OF CHRONIC MYELOID LEUKAEMIA IN RUSSIA

    Nov 1, 2010, 00:00

  • PMC4 COST ESTIMATION IN HEALTH ECONOMIC EVALUATIONS IN GERMANY- A SYSTEMATIC REVIEW

    Nov 1, 2010, 00:00

  • PGI9 HOSPITAL COST FOR TREATMENT OF PATIENTS WITH PEPTIC ULCER BLEED (PUB) IN SWEDEN-DATA FROM THE KPP (COST PER PATIENT) DATABASE

    Nov 1, 2010, 00:00

  • PIN3 PRESCRIBER INFLUENCE ON THE PREVALENCE OF POTENTIAL ANTIRETROVIRAL DRUG-DRUG INTERACTIONS ON PRESCRIPTIONS IN SOUTH AFRICA

    Nov 1, 2010, 00:00

  • PSS12 PSYCHOMETRIC EVALUATION OF MYOPIA-SPECIFIC INSTRUMENTS USED TO ASSESS HEALTH-RELATED QUALITY OF LIFE FOR PATIENTS RECEIVING LASIK SURGERY

    Nov 1, 2010, 00:00

  • PIH27 ASSESSMENT OF HEALTH RELATED QUALITY OF LIFE (HRQOL) AMONG NON-PRESCRIPTION MEDICINE CUSTOMERS IN MALAYSIA

    Nov 1, 2010, 00:00

  • PCN68 COST-EFFECTIVENESS OF PRIMARY PROPHYLAXIS WITH PEGFILGRASTIM VERSUS FILGRASTIM FOR THE PREVENTION OF FEBRILE NEUTROPENIA IN NON-HODGKIN LYMPHOMA AND STAGE II BREAST CANCER PATIENTS IN GERMANY

    Nov 1, 2010, 00:00

  • PSS2 USE OF INCREASED DOSAGES OF BIOLOGICS IN PLAQUE PSORIASIS AND POTENTIAL SAVINGS BY TREATING HIGH-DOSE PATIENTS WITH USTEKINUMAB INSTEAD-A BUDGET IMPACT MODEL

    Nov 1, 2010, 00:00

  • IR3 THE USE OF IRT MODELING TO ACCOUNT FOR DIFFERENTIAL ITEM FUNCTIONING IN THE PROQOL-HIV QUESTIONNAIRE

    Nov 1, 2010, 00:00

  • PIN68 EFFECT OF THE ANTIBIOTICS USE MONITORING PROGRAM FOR THE ACUTE UPPER-RESPIRATORY INFECTIONS DISEASE IN KOREAN CLINICS

    Nov 1, 2010, 00:00

  • PRS27 COUNTRY ADAPTATION OF A HEALTH ECONOMIC MODEL-THE CASE FOR ROFLUMILAST IN THE NETHERLANDS

    Nov 1, 2010, 00:00

  • PIH20 HEALTH-RELATED QUALITY OF LIFE IN CHINESE CHRONIC PROSTATITIS PATIENTS

    Nov 1, 2010, 00:00

  • PCV42 CLINICAL OUTCOMES FROM PHARMACIST-MANAGED ANTICOAGULATION CLINICS (ACC) IN PRIMARY CARE SETTINGS IN SINGAPORE

    Nov 1, 2010, 00:00

  • PCN13 COST-BENEFIT ANALYSIS OF A 21-GENE RECURRENCE SCORE FOR EARLY STAGE BREAST CANCER IN SINGAPORE

    Nov 1, 2010, 00:00

  • PIN17 COST-EFFECTIVENESS ANALYSIS OF THE NEW PCV-13 VACCINE WHEN COMPARED TO NO VACCINATION FROM A PUBLIC HEALTH-CARE SYSTEM PERSPECTIVE IN HONG KONG

    Nov 1, 2010, 00:00

  • PCV45 MEDICAL MALPRACTICE AND LITIGATION-WHAT DOES THIS MEAN FOR THE COST-EFFECTIVENESS OF DIAGNOSING CHEST PAIN?

    Nov 1, 2010, 00:00

  • PMH33 ADJUNCTIVE ANTIPSYCHOTICS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER IN TURKEY-A HEALTH ECONOMIC PERSPECTIVE

    Nov 1, 2010, 00:00

  • PMS78 WORSE 6-MONTH BASELINE HAQ AND THE SELF-REPORTED RHEUMATOID ARTHRITIS DISEASE ACTIVITY INDEX PREDICT IMPROVEMENT IN THEIR SCORES 6 MONTHS LATER, AMONG RHEUMATOID ARTHRITIS PATIENTS

    Nov 1, 2010, 00:00

  • PSY19 PREDICTORS OF DULOXETINE TREATMENT INITIATION AMONG PATIENTS WITH DIABETIC PERIPHERAL NEUROPATHIC PAIN IN SOUTH CENTER VETERANS AFFAIRS HEALTH CARE NETWORK IN THE UNITED STATES

    Nov 1, 2010, 00:00

  • PCV11 EFFECTS OF MEDICATION SUPPLY ON HEALTH-CARE COSTS AND RE-HOSPITALIZATIONS IN PATIENTS WITH CHRONIC HEART FAILURE

    Nov 1, 2010, 00:00

  • PSY24 COST OF CARE FOR CHRONIC MYELOID LEUKEMIA (CML) IN PATIENTS EXPERIENCING RESISTANCE AND/OR INTOLERANCE TO IMATINIB FROM THE PUBLIC HEALTH SYSTEM PERSPECTIVE IN MEXICO

    Nov 1, 2010, 00:00

  • PCN62 SURVEY AND ANALYSIS OF THE COSTS OF METASTATIC COLORECTAL CANCER TREATMENT IN SLOVAKIA

    Nov 1, 2010, 00:00

  • PIH58 HEALTH AND ECONOMY- A GOVERNMENTAL PERSPECTIVE, NATIONAL ACCOUNTING MODEL FOR ASSESSING INVESTMENTS IN ROTAVIRUS VACCINATION

    Nov 1, 2010, 00:00

  • PHP19 ANALYSIS OF THE GREEK PHARMACEUTICAL MARKET-THE FRAMEWORK, THE FACTS AND THE TRENDS (1998-2008)

    Nov 1, 2010, 00:00

  • PCV32 BUDGET IMPACT ANALYSIS OF PACLITAXEL DRUG ELUTING STENT (DES) FOR THE TREATMENT OF LOWER LIMB PERIPHERAL ARTERIAL DISEASE (PAD) IN FRANCE

    Nov 1, 2010, 00:00

  • PHP29 THE EFFECTS OF NICE APPRAISALS ON PRESCRIBING AND COSTSHARING BEHAVIOR IN THE US

    Nov 1, 2010, 00:00

  • ISPOR 4th Asia-Pacific Conference Author Index

    Nov 1, 2010, 00:00

  • PHP101 EVALUATION OF ACCEPTANCE AND REJECTION RATES OF ORPHAN DRUGS ACROSS SIX HTA BODIES

    Nov 1, 2010, 00:00

  • PHP105 HOW CAN THE USE OF PREDICTIVE BIOMARKERS LEAD TO POSITIVE HTA RECOMMENDATIONS?

    Nov 1, 2010, 00:00

  • PCV107 VALUATION OF HEALTH STATE UTILITIES RELATED TO CARDIOVASCULAR PREVENTION WITH ASPIRIN

    Nov 1, 2010, 00:00

  • PMH1 THE EFFICACY OF DONEPEZIL AND MEMANTINE FOR TREATING BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA (BPSD) IN PATIENTS WITH ALZHEIMERS DISEASE- SYSTEMATIC REVIEW AND META-ANALYSIS

    Nov 1, 2010, 00:00

  • PHP14 PHARMACEUTICAL PROCUREMENT AND SUPPLY CHAIN IN PUBLIC AND PRIVATE SECTOR IN DELHI, INDIA

    Nov 1, 2010, 00:00

  • PCN32 COMPARING FORECASTED WITH ACTUAL BUDGET IMPACT- REIMBURSED CANCER DRUGS IN THE NETHERLANDS

    Nov 1, 2010, 00:00

  • PSY9 THE ADMINISTRATION OF LIQUID INTRAVENOUS IMMUNOGLOBULINS IN SPAIN- A BUDGET IMPACT ANALYSIS TO ESTIMATE COSTS DUE TO AN INCREASING PRIVIGEN PENETRATION

    Nov 1, 2010, 00:00

  • PCV15 DIRECT MEDICAL COSTS FOR PULMONARY EMBOLISM AFTER ORTHOPEDIC SURGERY IN SLOVAKIA

    Nov 1, 2010, 00:00

  • PMS70 THE MANAGEMENT OF OSTEOARTHRITIS- ECONOMY OF NSAIDS

    Nov 1, 2010, 00:00

  • PMH55 THE SUBJECTIVE WELL-BEING UNDER NEUROLEPTIC SCALE SHORT FORM (SWN-K20) AND THE SF-36 AS QUALITY OF LIFE MEASURES IN SCHIZOPHRENIC PATIENTS

    Nov 1, 2010, 00:00

  • PCV103 COST IMPLICATION OF UNACCEPTABLE REFILL-BASED ADHERENCE RATES OF ANTIHYPERTENSION TREATMENT IN THE SOUTH AFRICAN PRIVATE HEALTH CARE ENVIRONMENT

    Nov 1, 2010, 00:00

  • PCV40 CLINICAL AND ECONOMIC IMPACT OF USE OF A POCKET-SIZED ULTRASOUND DEVICE FOR HEART FAILURE HOSPITALIZATIONS IN ITALY

    Nov 1, 2010, 00:00

  • PCV108 METHODS FOR ESTIMATING HEALTH-STATE UTILITIES IN PULMONARY ARTERIAL HYPERTENSION

    Nov 1, 2010, 00:00

  • PMH3 DETERMINANTS OF PSYCHIATRIC HOSPITAL ADMISSION IN SCHIZOPHRENIA

    Nov 1, 2010, 00:00

  • PCV100 THE EFFECTS OF DOSING COMPLEXITY ON ADHERENCE WITH PRESCRIPTION MEDICATIONS COMMONLY USED FOR CARDIOVASCULAR PATIENTS

    Nov 1, 2010, 00:00

  • PIN38 AN ECONOMIC EVALUATION OF THE PEDIATRIC VACCINATION SCHEDULE IN THE UNITED STATES

    Nov 1, 2010, 00:00

  • PUK33 TEST-RETEST RELIABILITY AND ACCLIMATION EFFECT OF PATIENT PERCEPTION OF INTENSITY OF URGENCY SCALE (PPIUS) FOR OVERACTIVE BLADDER

    Nov 1, 2010, 00:00

  • MT4 MIXED TREATMENT COMPARISON (MTC) OF ANTIFUNGAL DRUGS FOR PROPHYLAXIS TREATMENT AGAINST INVASIVE FUNGAL INFECTIONS (IFIS) IN PATIENTS RECEIVING CHEMOTHERAPY FOR HEMATOLOGICAL MALIGNANCIES OR ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANT ...

    Nov 1, 2010, 00:00

  • PSY6 COST-EFFECTIVENESS OF ORAL TRIPTAN THERAPY IN KOREA

    Nov 1, 2010, 00:00

  • PSY29 DARBEPOETIN ALFA VERSUS EPOETIN ALFA FOR TREATMENT OF CHEMOTHERAPY-INDUCED ANEMIA-A HEALTH ECONOMIC EVALUATION

    Nov 1, 2010, 00:00

  • PMH37 COST-EFFECTIVENESS OF ANTIPSYCHOTICS FOR THE TREATMENT OF RELAPSE PREVENTION FOR SCHIZOPHRENIA-THE SPANISH PERSPECTIVE

    Nov 1, 2010, 00:00

  • PMH21 SOCIETAL COSTS OF BIPOLAR DISORDER-THE CASE OF SWEDEN

    Nov 1, 2010, 00:00

  • PHP26 VALIDATION OF ELECTRONIC DATABASE IN COMMUNITY HOSPITALS IN PATIENTS WITH ATRIAL FIBRILLATION

    Nov 1, 2010, 00:00

  • PUK8 BUDGET IMPACT ANALYSIS OF ALISKIRENO IN TYPE 2 DIABETES PATIENTS WITH HYPERTENSION AND NEPHROPATHY IN THE MEXICAN INSTITUTE OF SOCIAL SECURITY

    Nov 1, 2010, 00:00

  • PR1 THE APPLICATION OF PHARMACOECONOMIC MODELING TO ESTIMATE A VALUE-BASED PRICE FOR NEW CANCER DRUGS IN A PUBLICLY FUNDED HEALTH-CARE SYSTEM

    Nov 1, 2010, 00:00

  • AD3 A CONCEPTUAL FRAMEWORK THAT CAPTURES THE MULTIDIMENSIONAL ASPECT OF ADHERENCE IN A HEALTHECONOMIC MODEL- AN APPLICATION IN CHRONIC NONMALIGNANT PAIN MANAGEMENT

    Nov 1, 2010, 00:00

  • PMC8 PREDICTING THE SF-6D PREFERENCE-BASED INDEX SCORE USING THE SF-8 HEALTH SURVEY

    Nov 1, 2010, 00:00

  • PMS8 OCCURRENCE OF SECUNDARY HIP AND FEMUR FRACTURES ACCORDING TO RISK FACTORS FOLLOW-UP 8 YEARS

    Nov 1, 2010, 00:00

  • PCV98 IMPACT OF MEDICATION ADHERENCE ON HEALTH CARE EXPENDITURES BY MEDICARE BENEFICIARIES WITH HEART FAILURE

    Nov 1, 2010, 00:00

  • PRS2 CARESS-THE CANADIAN REGISTRY OF SYNAGIS (2006-2009)

    Nov 1, 2010, 00:00

  • PMS39 COST-EFFECTIVENESS OF RITUXIMAB VERSUS ALTERNATIVE ANTI-TUMOR NECROSIS FACTOR (TNF) THERAPY AFTER PREVIOUS FAILURE OF ONE ANTI-TNF AGENT FOR TREATMENT OF RHEUMATOID ARTHRITIS IN COSTA RICA

    Nov 1, 2010, 00:00

  • PUK34 PSYCHOMETRIC VALIDATION OF THE SPANISH VERSION OF THE TREATMENT BENEFIT SCALE (TBS) FOR ASSESSING SUBJECTIVE OUTCOMES IN TREATING PATIENTS WITH OVERACTIVE BLADDER

    Nov 1, 2010, 00:00

  • ME4 DEVELOPMENT OF STANDARD COST LIST FOR ECONOMIC EVALUATION IN THAILAND

    Nov 1, 2010, 00:00

  • IN4 HERPES ZOSTER-ASSOCIATED ILLNESSES, QUALITY OF LIFE AND HEALTH-CARE COSTS AMONG 180 THAI PATIENTS

    Nov 1, 2010, 00:00

  • PMS54 GAP BETWEEN PATIENT-REPORTED ESTIMATION ON FRACTURE RISK AND THE WHO ASSESSMENT TOOL (FRAX) IN POSTMENOPAUSAL OSTEOPOROSIS

    Nov 1, 2010, 00:00

  • PHP57 AN ANALYSIS OF DRUG COST CONTAINMENT POLICY AT A HOSPITAL IN SOUTHERN THAILAND

    Nov 1, 2010, 00:00

  • PSY40 COST-EFFECTIVENESS OF PREGABALIN VERSUS USUAL CARE IN REFRACTORY OUT-PATIENTS WITH NEUROPATIC PAIN FOLLOWED IN PRIMARY CARE SETTINGS

    Nov 1, 2010, 00:00

  • PHP85 ASSESSING PUBLIC ACCOUNTABILITY OF KOREAN DRUG REIMBURSEMENT DECISION PROCESS

    Nov 1, 2010, 00:00

  • PCN148 IMAGING TESTS IN STAGING AND SURVEILLANCE OF EARLY BREAST CANCER (EBC) IN ITALY-CHANGES IN ROUTINE CLINICAL PRACTICE AND COSTS IMPLICATIONS

    Nov 1, 2010, 00:00

  • PDB67 FACTORS INFLUENCING VALUATION OF- AND WILLINGNESS TO PARTICIPATE IN- A LIFESTYLE INTERVENTION- AN EXPLORATORY CONJOINT ANALYSIS WITH DIABETES TYPE 2 PATIENTS

    Nov 1, 2010, 00:00

  • PSY25 A PHARMACOECONOMIC EVALUATION OF ROMIPLOSTIM (NPLATE) FOR THE TREATMENT OF CHRONIC IMMUNE THROMBOCYTOPENIA (ITP)

    Nov 1, 2010, 00:00

  • PDB53 COST-EFFECTIVENESS OF PREGABALIN VERSUS USUAL CARE IN REFRACTORY OUT-PATIENTS WITH PAINFUL DIABETIC PERIPHERAL NEUROPATHY (PDPN) FOLLOWED IN PRIMARY CARE SETTINGS

    Nov 1, 2010, 00:00

  • PDB39 EFFECT OF VARYING MODELLING ASSUMPTIONS ON THE COSTEFFECTIVENESS OF LIRAGLUTIDE 1.2 MG (AS A COMPONENT OF DUAL THERAPY) IN TYPE 2 DIABETES

    Nov 1, 2010, 00:00

  • PCN13 EFFECT OF ZOLEDRONIC ACID AND PAMIDRONATE ON SKELETALRELATED EVENTS AND MORTALITY IN WOMEN WITH BONE METASTASES FROM BREAST CANCER IN A MANAGED CARE PLAN- A RETROSPECTIVE DATABASE ANALYSIS

    Nov 1, 2010, 00:00

  • PCN82 RESEARCH PRIORITIZATION FOR PROSPECTIVE COMPARATIVE EFFECTIVENESS RESEARCH (CER) IN CANCER GENOMICS

    Nov 1, 2010, 00:00

  • PRS8 A COMPARISON OF CLINICAL EFFICACY AND SAFETY OF CICLESONIDE WITH BUDESONIDE IN 1-1 AND 1-2 DOSE RATIOS IN THE TREATEMENT OF BRONCHIAL ASTHMA

    Nov 1, 2010, 00:00

  • PIH16 CONTENT AND PSYCHOMETRIC VALIDITY OF THE EYELASH SATISFACTION QUESTIONNAIRE (ESQ) IN CHINA

    Nov 1, 2010, 00:00

  • PMS73 LINKAGE OF ADMINISTRATIVE AND MEDICAL RECORDS DATABASES FOR INVESTIGATING PHARMACEUTICAL USE AND OUTCOMES

    Nov 1, 2010, 00:00

  • PHP22 UNIT COST OF BURMESE TRANSLATOR ACTIVITIES IN PHARMACY DEPARTMENT, SAMUTSAKHON HOSPITAL

    Nov 1, 2010, 00:00

  • DU1 THE IMPACTS OF ABUSE OF ANTIBIOTIC THERAPIES IN CHINA

    Nov 1, 2010, 00:00

  • PCV78 COST-EFFECTIVENESS ANALYSIS OF IVABRADINE IN CHRONIC STABLE ANGINA PATIENTS IN AN AUSTRIAN SETTING

    Nov 1, 2010, 00:00

  • PIN5 HOW LONGITUDINAL PATIENT RECORDS CAN HELP PUBLIC HEALTH AUTHORITIES IN THE MANAGEMENT OF RAPIDLY GROWING EPIDEMICS? THE EXPERIENCE OF FLU A/H1N1 IN FRANCE

    Nov 1, 2010, 00:00

  • PDB15 WEIGHT CHANGE FOR PATIENTS WITH TYPE 2 DIABETES- SECULAR TRENDS AND IMPACT OF DIFFERENT COMBINATIONS OF THERAPY

    Nov 1, 2010, 00:00

  • PCV121 A SURVEY OF PHYSICIANS ATTITUDES TOWARD THE CONTROL OF CARDIOVASCULAR RISK FACTORS. THE EURIKA STUDY.

    Nov 1, 2010, 00:00

  • PUK26 THE INFLUENCE OF FUTURE UNRELATED COSTS ON COSTEFFECTIVENESS ESTIMATES-TREATMENT OF HYPERPHOSPHATEMIA WITH LANTHANUM CARBONATE IN PRE-DIALYIS PATIENTS WITH CHRONIC KIDNEY DISEASE

    Nov 1, 2010, 00:00

  • PDB69 UTILITY VALUES FOR DIABETES COMPLICATIONS

    Nov 1, 2010, 00:00

  • PMS41 THE IMPACT OF MEDICATION ADHERENCE ON THE COST OF OSTEOPOROSIS FRACTURES IN GERMANY- A MODELLING APPROACH

    Nov 1, 2010, 00:00

  • PGI5 A BUDGET IMPACT ANALYSIS OF THE HEPATITIS C TREATMENT WITH PEGYLATED INTERFERON IN BRAZIL

    Nov 1, 2010, 00:00

  • PSY67 PREDICTING EQ-5D UTILITIES FROM NEUROPATHIC PAIN SCORES- COMPARING INDIRECT MAPPING OF PREDICTED ITEM RESPONSES WITH DIRECT MAPPING OF SCORES

    Nov 1, 2010, 00:00

  • PHP34 THE EVALUATION OF HEALTH-CARE SYSTEMS OF CHINA, HONG KONG, VIETNAM, THAILAND, MALAYSIA, SINGAPORE AND AUSTRALIA

    Nov 1, 2010, 00:00

  • PDB21 COMPARISON OF COSTS OF THE INSULIN TREATMENT OF TYPE 2 DIABETES MELLITUS WITH INSULIN GLARGINE AND INSULIN DETEMIR

    Nov 1, 2010, 00:00

  • MA3 GLAUCOMA DISEASE PROGRESSION STATES- ESTABLISHING A DIRECT, QUANTITATIVE LINK BETWEEN VISUAL FIELD DEFECTS AND UTILITY LOSS

    Nov 1, 2010, 00:00

  • PIN57 EVALUATION OF MEDICATION ADHERENCE IN PATIENTS RECEIVING ANTIRETROVIRAL THERAPY (ART) IN MAITAMA DISTRICT HOSPITAL, ABUJA NIGERIA

    Nov 1, 2010, 00:00

  • PSS35 COST COMPARISON OF PATIENTS WITH CHRONIC HAND ECZEMA COVERED BY STATUTORY VS. OCCUPATIONAL HEALTH INSURANCES IN GERMANY

    Nov 1, 2010, 00:00

  • PIN6 COMPARISON OF SOCIO-DEMOGRAPHIC AND CLINICAL FACTORS OF PULMONARY AND EXTRA PLUMONARY TUBERCULOSIS IN YEMEN

    Nov 1, 2010, 00:00

  • PCV9 RATE OF SUBSEQUENT CORONARY EVENTS AND DIRECT ECONOMIC OUTCOMES FOLLOWING AN ACUTE CORONARY EVENT BETWEEN PATIENTS AUGMENTING STATIN TO FURTHER REDUCE LDL-C VS. IMPROVING A COMPREHENSIVE LIPID PROFILE

    Nov 1, 2010, 00:00

  • PDB6 THE DISEASE BURDEN ANALYSIS OF 295 INPATIENTS WITH DIABETES MELLITUS FROM TONGJI HOSPITAL IN CHINA

    Nov 1, 2010, 00:00

  • PCN11 PREVENTION OF OXALIPLATIN HYPERSENSITIVITY REACTION AND COST SAVING

    Nov 1, 2010, 00:00

  • PSY49 PATIENTS PREFERENCES IN OVERWEIGHT AND OBESITY THERAPY WITH DISCRETE CHOICE EXPERIMENTS

    Nov 1, 2010, 00:00

  • PHP118 PERCEPTION OF PHARMACISTS SALES REPRESENTATIVES BY PHYSICIANS

    Nov 1, 2010, 00:00

  • PCV51 THE IMPACT OF ACQUIRED BRAIN DAMAGE IN TERMS OF EPIDEMIOLOGY, ECONOMICS AND LOSS IN QUALITY OF LIFE

    Nov 1, 2010, 00:00

  • PSS25 MAPPING THE IMPACT OF DRY EYE ON EVERYDAY LIFE (IDEEL) QUESTIONNAIRE TO A PREFERENCE BASED UTILITY INDEX

    Nov 1, 2010, 00:00

  • PIH32 EVALUATING THE PERCEPTION OF ACADEMIC PHARMACIST TOWARD THEIR ROLE IN HEALTH-CARE SYSTEM OF PAKISTAN

    Nov 1, 2010, 00:00

  • HE1 A CROSS-COUNTRY COMPRASION OF HEALTH PERFORMANCE BETWEEN TAX-FUNDED AND SOCIAL HEALTH INSURANCE SYSTEM- THE CHANNEL VIA PREVENTIVE CARE

    Nov 1, 2010, 00:00

  • PSS19 COST-EFFECTIVENESS OF AGE-RELATED MACULAR DEGENERATION- A MODEL

    Nov 1, 2010, 00:00

  • PIN3 SURGICAL SITE INFECTION IN AUSTRALIA- A SYSTEMATIC REVIEW OF THE INCIDENCE AND ECONOMIC BURDEN

    Nov 1, 2010, 00:00

  • PHP102 A SURVEY OF HTA RESEARCH METHODS AND TRENDS IN EUROPE

    Nov 1, 2010, 00:00

  • PGI32 USING DATA ENVELOPMENT ANALYSIS TO ESTABLISH THE EFFECTIVENESS EVALUATION OF DRUGS

    Nov 1, 2010, 00:00

  • PRS5 EVALUATING SAFETY OUTCOMES OF LONG-ACTING BETA AGONISTS (LABAS) IN PATIENTS WITH ASTHMA

    Nov 1, 2010, 00:00

  • PCN49 PREDICTORS OF THE DIRECT COSTS OF BREAST CANCER IN THE UNITED STATES ELDERLY POPULATION

    Nov 1, 2010, 00:00

  • PHP6 RECOMMENDATIONS FOR A BIOLOGICS-SPECIFIC PRICING SYSTEM IN CHINA

    Nov 1, 2010, 00:00

  • PCN164 THE ECONOMICS OF CHRONIC MYELOGENOUS LEUKEMIA- A COMPARISON OF MODELING APPROACHES

    Nov 1, 2010, 00:00

  • PIH49 PRESCRIBING PATTERNS OF SELECTIVE SEROTONIN RE-UPTAKE INHIBITORS AND SELECTIVE SEROTONIN AND NORADRENALINE RE-UPTAKE INHIBITORS IN CHILDREN AND ADOLESCENTS IN A SOUTH AFRICAN PRIVATE PRACTICE SETTING

    Nov 1, 2010, 00:00

  • PIN22 A NOVEL APPROACH FOR ESTIMATING THE VALUE OF ENTECAVIR THERAPY FOR NUCLEOSIDE-NAVE CHRONIC HEPATITIS B PATIENTS IN SPAIN

    Nov 1, 2010, 00:00

  • PHP114 DERIVING DOCTORS PRESCRIBING PATTERNS FROM HEALTH CARE CLAIMS- AN INSTRUMENTAL VARIABLE ANALYSIS

    Nov 1, 2010, 00:00

  • PGI4 BUDGET IMPACT ANALYSIS OF ORAL ANTIVIRAL AGENTS FOR THE TREATMENT OF CHRONIC HPATITIS B IN SOUTH KOREA

    Nov 1, 2010, 00:00

  • PMH11 COST-EFFECTIVENESS ANALYSIS FOR PHARMACOLOGICAL INTERVENTION AND COGNITIVE BEHAVIORAL TREATMENT (CBT) FOR MAJOR DEPRESSION IN THAILAND

    Nov 1, 2010, 00:00

  • PMC1 SURVIVAL ANALYSIS WITH COX REGRESSION MODELS-VALIDATING A WEB-BASED CALCULATOR

    Nov 1, 2010, 00:00

  • PRS23 COMPARISON OF DIFFERENT METHODS FOR ASSESSING ATTRIBUTABLE COSTS-A CASE OF MEDICAL COSTS ATTRIBUTABLE TO OBESE IN PATIENTS WITH ASTHMA

    Nov 1, 2010, 00:00

  • PMS11 HEALTH-CARE UTILIZATION OF PATIENTS WITH LOW BACK PAIN IN SOUTH KOREA (2006-2008)

    Nov 1, 2010, 00:00

  • PCV114 ABSENTEISM AND IMPAIRED QUALITY OF LIFE IN CHRONIC VENOUS DISEASE IN ROMANIA

    Nov 1, 2010, 00:00

  • PCV10 ANALYSIS OF INAPPROPRIATE SHOCKS IN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) DEVICES

    Nov 1, 2010, 00:00

  • PDB19 BUDGET IMPACT ANALYSIS OF SAXAGLIPTIN FOR THE TREATMENT OF TYPE 2 DIABETES IN MEXICAN POPULATION AT PEMEX

    Nov 1, 2010, 00:00

  • PHP125 TRENDS IN UK-BASED PATIENT ACCESS SCHEMES- FINANCIAL-BASED VERSUS OUTCOMES-BASED AGREEMENTS

    Nov 1, 2010, 00:00

  • PCN4 LIKELIHOOD OF A SUBSEQUENT CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) EVENT IN PATIENTS RECEIVING MODERATELY OR HIGHLY EMETOGENIC CHEMOTHERAPY (MEC/HEC)

    Nov 1, 2010, 00:00

  • PCN61 COST IMPACT OF ORAL CAPECITABINE COMPARED TO 5-FLUOROURACIL FOR TREATMENT OF PATIENTS WITH METASTATIC COLORECTAL CANCER

    Nov 1, 2010, 00:00

  • PSY16 CHANGES IN SELF-REPORTED PAIN SCORES ASSOCIATED WITH DULOXETINE VERSUS OTHER ANTIDEPRESSANTS AMONG PATIENTS WITH MAJOR DEPRESSIVE DISORDER IN THE UNITED STATES VETERANS AFFAIRS HEALTH CARE NETWORK

    Nov 1, 2010, 00:00

  • PMC31 CONSTRUCTION OF PRIMARY HUI3 PERSON-MEAN UTILITY SCORING FUNCTION

    Nov 1, 2010, 00:00

  • PRS36 ADHERENCE TO MEDICATION AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH COPD- SGRQ-AN ALTERNATIVE METHOD TO IDENTIFY NONADHERENCE

    Nov 1, 2010, 00:00

  • PIH23 A REVIEW OF POSITIVE LIST SYSTEM IN KOREA-ACHIEVEMENTS, CHALLENGES AND SUGGESTIONS

    Nov 1, 2010, 00:00

  • PSS6 COST OF ILLNESS OF PSORIASIS-A 1-MONTH PROSPECTIVE STUDY IN SOUTHERN SWEDEN

    Nov 1, 2010, 00:00

  • NI2 PATIENT ACCESS SCHEMES IN UK ARE DRIVEN BY HEALTH TECHNOLOGY ASSESMENT

    Nov 1, 2010, 00:00

  • PGI1 A SYSTEMATIC REVIEW OF THE DIAGNOSTIC ACCURACY OF SEROLOGIC TESTS IN THE DIAGNOSIS OF CELIAC DISEASE

    Nov 1, 2010, 00:00

  • PMS49 PSYCHOMETRIC PROPERTIES OF THE RHEUMATOID ARTHRITIS DISEASE ACTIVITY INDEX (RADAI) IN A COMMUNITY POPULATION IN THE US

    Nov 1, 2010, 00:00

  • PCV126 USE OF PROTON PUMP INHIBITORS (PPIS) IN ACUTE CORONARY SYNDROME PATIENTS TREATED WITH CLOPIDOGREL IN GERMANY, FRANCE, AND THE UNITED KINGDOM

    Nov 1, 2010, 00:00

  • PIH18 QUALITY OF LIFE IN THAI WOMEN DIAGNOSED WITH GENITAL WARTS, CERVICAL CANCER, AND CERVICAL INTRAEPITHELIAL NEOPLASIA AT KING CHULALONGKORN MEMORIAL HOSPITAL

    Nov 1, 2010, 00:00

  • PMH54 USE OF THE ANALYTIC HIERARCHY PROCESS TO PRIORITIZE PATIENT-RELEVANT ENDPOINTS OF ANTIDEPRESSANT TREATMENT

    Nov 1, 2010, 00:00

  • PMC4 CHOOSING THE RIGHT DISTRIBUTION WHEN PERFORMING PROBABILISTIC SENSITIVITY ANALYSIS- RELATIVE RISKS AND THE TRIANGULAR DISTRIBUTION A SIMULATION STUDY

    Nov 1, 2010, 00:00

  • PMH50 TRENDS IN ANTIDEPRESSANT UTILIZATION, AND ASSOCIATED LABOR MARKET PARTICIPATION AND QUALITY OF LIFE OUTCOMES IN THE UNITED STATES- 2004-2007

    Nov 1, 2010, 00:00

  • PHP111 PREDICTING PREVENTIVE CARE SERVICE UTILIZATION IN A UNITED STATES POPULATION

    Nov 1, 2010, 00:00

  • PDB10 LOWER EXTREMITY AMPUTATION PREVENTION (LEAP) IN SINGAPORE- ECONOMIC ANALYSIS OF RESULTS

    Nov 1, 2010, 00:00

  • PMH6 INCREASING ADMINISTRATIVE PREVALENCE OF ATTENTION-DEFICIT/ HYPERACTIVITY DISORDER (ADHD) IN GERMANY- EVIDENCE FROM NORDBADEN, 2003 TO 2008

    Nov 1, 2010, 00:00

  • PHP88 STAKEHOLDER PERCEPTIONS OF CLINICAL DRUG TRIALS

    Nov 1, 2010, 00:00

  • PIN63 PATIENT PREFERENCES FOR BENEFITS, RISKS, AND WEIGHT OF EVIDENCE ASSOCIATED WITH HEPATITIS B TREATMENTS

    Nov 1, 2010, 00:00

  • PHP1 A STUDY EVALUATING PATTERN OF NON-PRESCRIPTION PURCHASE BY CONSUMERS FROM COMMUNITY PHARMACIES IN MALAYSIA

    Nov 1, 2010, 00:00

  • PMS23 BURDEN OF ILLNESS OF OSTEOPOROSIS IN AUSTRIA

    Nov 1, 2010, 00:00

  • PMH27 RECENT TRENDS IN PSYCHIATRIC PRESCRIPTION DRUG SPENDING

    Nov 1, 2010, 00:00

  • PRS12 THE COST ANALYSIS OF BRONCHODILATOR PRESCRIPTIONS FOR TREATMENT OF STABLE COPD IN UKRAINE

    Nov 1, 2010, 00:00

  • PCN163 EXTENDING FIXED EFFECT MODELS TO CENSORED COST DATA

    Nov 1, 2010, 00:00

  • PMS15 FREQUENCY AND RISK FACTORS OF GOUT FLARES IN A LARGE POPULATION-BASED COHORT OF INCIDENT GOUT

    Nov 1, 2010, 00:00

  • PSY62 HEALTH TECHNOLOGY ASSESSMENT FOR RARE DISEASES- A MARKOVIAN MODEL FOR FABRY DISEASE (FD) CONSIDERING ENZYME REPLACEMENT THERAPY(ERT)

    Nov 1, 2010, 00:00

  • PCN129 A DATABASE REVIEW OF PATIENT-REPORTED OUTCOME STUDIES IN EORTC CANCER CLINICAL TRIALS

    Nov 1, 2010, 00:00

  • PHP27 USING COLLABORATIVE PROGRAM BETWEEN PHARMACISTS AND NURSES YO IMPROVE SPONTANEOUS ADVERSE DRUG REACTION REPORTING SYSTEM IN THAILAND

    Nov 1, 2010, 00:00

  • PMH12 COST-EFFECTIVENESS OF TYPICALS, ATYPICALS AND PSYCHOSOCIAL INTERVENTIONS FOR SCHIZOPHRENIA IN THAILAND

    Nov 1, 2010, 00:00

  • PIN17 IMPACT OF YELLOW FEVER OUTBREAKS IN BRAZIL, 2000-2009

    Nov 1, 2010, 00:00

  • PDB28 THE EFFECT OF METFORMIN BRAND SHIFT BY HOSPITAL ON ANTIDIABETICS UTILIZATION

    Nov 1, 2010, 00:00

  • PSY8 ACCESS TO CARE AND HEALTH OUTCOMES AMONG THE SEVERE HEMOPHILIA A POPULATION IN CHINA TODAY

    Nov 1, 2010, 00:00

  • PDB30 USE OF MEDICAL INFORMATION SYSTEM FOR ASSESSMENT OF THE COST OF THERAPY OF DIABETIC FOOT PATIENTS IN RUSSIA

    Nov 1, 2010, 00:00

  • PCV65 HEALTH ECONOMIC ASSESSMENT OF FERRIC CARBOXYMALTOSE IN PATIENTS WITH IRON DEFICIENCY AND CHRONIC HEART FAILURE IN THE FAIR-HF TRIAL

    Nov 1, 2010, 00:00

  • PCN136 QUALITY OF LIFE AFTER CHEMOTHERAPY IN BREAST CANCER-A STUDY IN SOUTH OF IRAN

    Nov 1, 2010, 00:00

  • PCV53 THE BURDEN OF ISCHEMIC HEART DISEASES AT A MAJOR CARDIAC CENTER IN RIYADH, SAUDI ARABIA

    Nov 1, 2010, 00:00

  • PCV101 THE IMPACT OF MEDICATION SWITCHES INDUCES BY MEDICATION DISCOUNT CONTRACTS ON CHRONIC PATIENTS ADHERENCE

    Nov 1, 2010, 00:00

  • PHP122 COMPETITIVENESS OF HUNGARY IN INTERNATIONAL CLINICAL TRIALS

    Nov 1, 2010, 00:00

  • PCN167 INFORMING THE DECISION- IMPROVING GENERALIZABILITY BY PARAMETERIZING RELEVANT INFORMATION IN THE ECONOMIC EVALUATION OF TRASTUZUMAB IN EARLY BREAST CANCER

    Nov 1, 2010, 00:00

  • PUK13 INCIDENCE AND COST OF HOSPITALIZATIONS FOR ACUTE URINARY RETENTION ATTRIBUTABLE TO BENIGN PROSTATE HYPERPLASIA IN FRANCE

    Nov 1, 2010, 00:00

  • PHP48 ECONOMIC EVALUATION OF HEALTH CARE INTERVENTIONS DURING MORE THAN 25 YEARS IN SPAIN (1983-2008)

    Nov 1, 2010, 00:00

  • PIN60 CLINICAL PROFILE AND ADHERENCE PATTERN OF ANTI-RETROVIRAL THERAPY OF PEOPLE LIVING WITH HIV/AIDS REGISTERED AT DISTRICT ANTI RETROVIRAL THERAPY CENTRE, UDUPI DISTRICT

    Nov 1, 2010, 00:00

  • PDB29 COST OF DIABETES MELLITUS TYPE 1 AND 2 STUDIES IN COUNTRIES OF CENTRAL AND EASTERN EUROPE-A SYSTEMATIC REVIEW OF THE LITARATURE

    Nov 1, 2010, 00:00

  • PIN7 ANTIFUNGAL TREATMENT FOR INVASIVE CANDIDIASIS- SYSTEMATIC REVIEW AND META-ANALYSIS

    Nov 1, 2010, 00:00

  • PMH49 ANTIDEPRESSANT UTILIZATION, ADHERENCE AND HEALTH CARE SPENDING IN THE UNITED STATES-THE CASE OF MDD PATIENTS 2000-2007

    Nov 1, 2010, 00:00

  • PCV43 PHYSICIAN-LEVEL CLASS EFFECT ON 90-DAY BLOOD PRESSURE VALUES- A META-ANALYSIS OF MULTILEVEL OBSERVATIONAL STUDIES OF VALSARTAN ANTIHYPERTENSIVE EFFECTIVENESS

    Nov 1, 2010, 00:00

  • PSS2 COMPARISON OF COSTING METHODS- COST TO CHARGE RATIO AND DIAGNOSIS RELATED GROUP USING STEVENS-JOHNSON SYNDROME AND TOXIC EPIDERMAL NECROLYSIS AS A CASE STUDY

    Nov 1, 2010, 00:00

  • PIN79 IS IT POSSIBLE TO OBTAIN WILLINGNESS-TO-PAY ESTIMATES IN EUROPE? A VALIDITY TEST OF STATED PREFERENCES FOR HEPATITIS-B TREATMENTS

    Nov 1, 2010, 00:00

  • PMH4 LABOR FORCE WITHDRAWAL OF PATIENTS WITH PSYCHIATRIC ILLNESS IN TAIWAN

    Nov 1, 2010, 00:00

  • EQ4 DESCRIBING AND COMPARING HEALTH-RELATED QUALITY OF LIFE DERIVED FROM EQ-5D AND SF-6D IN A SWEDISH GENERAL POPULATION

    Nov 1, 2010, 00:00

  • PIH21 QUALITY OF LIFE IMPACT IN PARENTS CARING FOR SEVERE GASTROENTERITIS IN CHILDREN IN SEVEN COUNTRIES WORLDWIDE

    Nov 1, 2010, 00:00

  • PMC55 SYSTEMATIC REVIEW OF METHODS FOR META-ANALYSIS AND INDIRECT COMPARISON USED IN EXISTING SYSTEMATIC REVIEWS AND HTA REPORTS-RESULTS FROM THE FIRST PART OF EBAYESMET PROJECT

    Nov 1, 2010, 00:00

  • PIH25 THE IMPACT OF EMPLOYEES WORK ABSENTEEISM DUE TO CARE FOR A SICK PERSON ON PRODUCTIVITY IN POLAND

    Nov 1, 2010, 00:00

  • PCV24 THE IMPACT OF METABOLIC SYNDROME ON QUALITY OF LIFE AND RESOURCE USE IN CHINA AND THE UNITED STATES

    Nov 1, 2010, 00:00

  • PSY35 THE COST-EFFECTIVENESS OF DULOXETINE IN THE TREATMENT OF FIBROMYALGIA IN THE UNITED STATES

    Nov 1, 2010, 00:00

  • PCV8 EVALUATION OF CLINICAL AND DIRECT ECONOMIC OUTCOMES FOLLOWING AN ACUTE CORONARY EVENT AMONG PATIENTS WITH SUBOPTIMAL HDL-C OR TRIGLYCERIDES ADMINISTERED EITHER STATIN AND NIACIN EXTENDED-RELEASE OR STATIN MONOTHERAPY

    Nov 1, 2010, 00:00

  • PRS44 EFFECTIVENESS AND EFFICIENCY OF ME-TOO LISTS AS ILLUSTRATED BY THE EXAMPLE OF INTRANASAL STEROIDS

    Nov 1, 2010, 00:00

  • PMH8 HEALTH-CARE UTILIZATION COSTS AMONG SCHIZOPHRENIA PATIENTS TREATED WITH OLANZAPINE OR RISPERIDONE IN JAPAN

    Nov 1, 2010, 00:00

  • PHP91 REGIONAL DIFFERENCES IN NUMBER OF PSYCHIATRIC BEDS IN HUNGARY FOLLOWING THE 2007 HEALTH CARE REFORM IN HUNGARY

    Nov 1, 2010, 00:00

  • PSY61 RISK OF SURGICAL PROCEDURES IN THE INFLAMMATORY BOWEL DISEASE. ADMINISTRATIVE DATABASES AS A RESOURCE OF KNOWLEDGE

    Nov 1, 2010, 00:00

  • PCV135 CREATING AN EFFICIENT HOSPITAL PAYMENT SYSTEM

    Nov 1, 2010, 00:00

  • PMH21 PHYSICIAN PRESCRIBING PATTERNS IN INNOVATIVE ANTIDEPRESSANTS IN THE UNITED STATES-THE CASE OF PATIENTS WITH MAJOR DEPRESSIVE DISORDER

    Nov 1, 2010, 00:00

  • CE3 COST-UTILITY ANALYSIS OF CHOLINESTERASE INHIBITORS IN THE TREATMENT OF MILD TO MODERATE ALZHEIMERS DISEASE

    Nov 1, 2010, 00:00

  • PMS19 THE INTRODUCTION OF A GERMAN ARTHROPLASTY REGISTER- COST SAVINGS FOR THE HEALTH CARE SYSTEM

    Nov 1, 2010, 00:00

  • PIH4 COMPARING THE MODEL PREDICTED VACCINE IMPACT AGAINST ROTAVIRUS HOSPITALIZATION WITH OBSERVED DATA IN BELGIUM

    Nov 1, 2010, 00:00

  • PCN65 COST-EFFECTIVENESS ANALYSIS OF A FOBT-BASED COLORECTAL CANCER SCREENING PROGRAMME

    Nov 1, 2010, 00:00

  • PCN40 COST ANALYSIS OF MANAGING ADVERSE EVENTS IN THE TREATMENT OF METASTATIC RENAL CELL CARCINOMA IN PORTUGAL- A COMPARISON OF BEVACIZUMAB IN COMBINATION WITH INTERFERON ALFA-2A AND SUNITINIB

    Nov 1, 2010, 00:00

  • MO1 STRUCTURAL UNCERTAINTY IN COST-EFFECTIVENESS MODELS OF TREATMENT FOR ALZHEIMERS DISEASE

    Nov 1, 2010, 00:00

  • PMS67 CONJOINT ANALYSIS OF REDUCTION OF CO-PAYMENT RATE OF NATIONAL HEALTH INSURANCE SYSTEM IN JAPAN

    Nov 1, 2010, 00:00

  • PCV37 BURDEN IMPACT OF ATRIAL FIBRILLATION (AF BI) IN RUSSIAN FEDERATION

    Nov 1, 2010, 00:00

  • PDB55 COMPARISON OF RESOURCE USE AND COSTS IN TYPE 1 DIABETES PATIENTS TREATED WITH DIFFERENT LONG ACTING INSULINS IN A BASAL-BOLUS REGIMEN IN GERMANY

    Nov 1, 2010, 00:00

  • PCN28 TRANSLATION AND VALIDATION OF EORTC QLQ-C30 INTO INDONESIAN VERSION FOR CANCER PATIENTS IN INDONESIA

    Nov 1, 2010, 00:00

  • PIN11 COSTS OF QUANTIFERON TB-GOLD VERSUS TUBERCULIN SKIN TEST IN SPANISH HEALTH CARE WORKERS

    Nov 1, 2010, 00:00

  • PMH19 THE BURDEN OF DIAGNOSED, SELF-REPORTED, AND AT-RISK DEPRESSION IN CHINA AND EUROPE

    Nov 1, 2010, 00:00

  • PCN15 COST ANALYSIS BETWEEN TYROSINE KINASE INHIBITOR VERSUS DOCETAXEL IN ADVANCED NON-SMALL CELL LUNG CANCER

    Nov 1, 2010, 00:00

  • PCV94 POTENTIAL COST-EFFECTIVENESS OF A BIOMARKER TEST TO STRATIFY PATIENTS INDICATED FOR A CORONARY STENT

    Nov 1, 2010, 00:00

  • PCN146 HEALTH RESOURCE UTILIZATION OF SUBJECTS RECEIVING DENOSUMAB AND ZOLEDRONIC ACID IN A RANDOMIZED PHASE 3 TRIAL OF ADVANCED BREAST CANCER PATIENTS WITH BONE METASTASES

    Nov 1, 2010, 00:00

  • PHP106 HTAINSITE-A DATABASE OF NICE SUBMISSIONS AND DECISIONS

    Nov 1, 2010, 00:00

  • PMC54 TREATMENT SATISFACTION INSTRUMENTS FOR DIFFERENT PURPOSES DURING A PRODUCTS LIFECYCLE-KEEPING THE END IN MIND

    Nov 1, 2010, 00:00
  • «
  • 131 (current)
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • »